Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts. more
Time Frame | HLVX | Sector | S&P500 |
---|---|---|---|
1-Week Return | -7.58% | -3.35% | -2.97% |
1-Month Return | 0.55% | -3.49% | -0.66% |
3-Month Return | 1.1% | -12.6% | 2.71% |
6-Month Return | -85.74% | -6.91% | 7.21% |
1-Year Return | -87.81% | 1.19% | 23.04% |
3-Year Return | -90.41% | -0.21% | 28.43% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | - | - | 3.00K | 2.25M | 2.16M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.13,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":95.74,"profit":true}] |
Gross Profit | - | - | (3.00K) | (2.25M) | (2.16M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-300000,"profit":false},{"date":"2022-12-31","value":-225200000,"profit":false},{"date":"2023-12-31","value":-215600000,"profit":false}] |
Gross Margin | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Operating Expenses | 633.00K | 1.29M | 15.77M | 62.61M | 133.34M | [{"date":"2019-12-31","value":0.47,"profit":true},{"date":"2020-12-31","value":0.97,"profit":true},{"date":"2021-12-31","value":11.83,"profit":true},{"date":"2022-12-31","value":46.96,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (633.00K) | (1.29M) | (53.43M) | (65.11M) | (133.34M) | [{"date":"2019-12-31","value":-63300000,"profit":false},{"date":"2020-12-31","value":-129500000,"profit":false},{"date":"2021-12-31","value":-5342600000,"profit":false},{"date":"2022-12-31","value":-6511300000,"profit":false},{"date":"2023-12-31","value":-13334500000,"profit":false}] |
Total Non-Operating Income/Expense | - | (837.00K) | (51.83M) | (94.23M) | 16.79M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-4.98,"profit":false},{"date":"2021-12-31","value":-308.65,"profit":false},{"date":"2022-12-31","value":-561.22,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (673.00K) | (2.10M) | (102.41M) | (159.81M) | (123.57M) | [{"date":"2019-12-31","value":-67300000,"profit":false},{"date":"2020-12-31","value":-210300000,"profit":false},{"date":"2021-12-31","value":-10240800000,"profit":false},{"date":"2022-12-31","value":-15980900000,"profit":false},{"date":"2023-12-31","value":-12356600000,"profit":false}] |
Income Taxes | (633.00) | 29.00K | (17.38M) | 97.20M | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":0.03,"profit":true},{"date":"2021-12-31","value":-17.88,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | - | (2.13M) | (85.03M) | (257.00M) | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-213200000,"profit":false},{"date":"2021-12-31","value":-8502500000,"profit":false},{"date":"2022-12-31","value":-25700500000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
Income From Continuous Operations | - | (2.10M) | (102.41M) | (159.81M) | (107.79M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-210300000,"profit":false},{"date":"2021-12-31","value":-10240800000,"profit":false},{"date":"2022-12-31","value":-15980900000,"profit":false},{"date":"2023-12-31","value":-10779400000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (673.00K) | (2.13M) | (85.03M) | (257.00M) | (123.57M) | [{"date":"2019-12-31","value":-67300000,"profit":false},{"date":"2020-12-31","value":-213200000,"profit":false},{"date":"2021-12-31","value":-8502500000,"profit":false},{"date":"2022-12-31","value":-25700500000,"profit":false},{"date":"2023-12-31","value":-12356600000,"profit":false}] |
EPS (Diluted) | - | - | (9.01) | (13.10) | (3.04) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-901,"profit":false},{"date":"2022-12-31","value":-1310,"profit":false},{"date":"2023-12-31","value":-304,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
HLVX | |
---|---|
Cash Ratio | 13.68 |
Current Ratio | 14.25 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
HLVX | |
---|---|
ROA (LTM) | -28.90% |
ROE (LTM) | -62.24% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
HLVX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.16 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.84 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
HLVX | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 0.51 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
Hillevax Inc (HLVX) share price today is $1.83
Yes, Indians can buy shares of Hillevax Inc (HLVX) on Vested. To buy Hillevax Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HLVX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Hillevax Inc (HLVX) via the Vested app. You can start investing in Hillevax Inc (HLVX) with a minimum investment of $1.
You can invest in shares of Hillevax Inc (HLVX) via Vested in three simple steps:
The 52-week high price of Hillevax Inc (HLVX) is $20.22. The 52-week low price of Hillevax Inc (HLVX) is $1.55.
The price-to-earnings (P/E) ratio of Hillevax Inc (HLVX) is
The price-to-book (P/B) ratio of Hillevax Inc (HLVX) is 0.51
The dividend yield of Hillevax Inc (HLVX) is 0.00%
The market capitalization of Hillevax Inc (HLVX) is $92.64M
The stock symbol (or ticker) of Hillevax Inc is HLVX